Invention Grant
- Patent Title: 1,2,4-triazine-4-amine derivatives
-
Application No.: US17239137Application Date: 2021-04-23
-
Publication No.: US12054472B2Publication Date: 2024-08-06
- Inventor: Miles Stuart Congreve , Stephen Philippe Andrews , Jonathan Stephen Mason , Christine Mary Richardson , Giles Albert Brown
- Applicant: Nxera Pharma UK Limited
- Applicant Address: GB Cambridge
- Assignee: Nxera Pharma UK Limited
- Current Assignee: Nxera Pharma UK Limited
- Current Assignee Address: GB Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/4427 ; A61K31/53 ; A61K31/5355 ; A61K31/5377 ; A61K31/5386 ; C07D253/07 ; C07D401/04 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D403/12 ; C07D405/04 ; C07D405/10 ; C07D413/04 ; C07D413/14 ; C07D417/04 ; C07D417/12 ; C07D417/14 ; C07D487/04

Abstract:
According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1-A2b or, particularly, the A2a receptor. A process for the preparation of the compound, pharmaceutical compositions comprising the compound, and methods of treatment comprising administration of an effective amount of the compound are also disclosed.
Public/Granted literature
- US20230021177A1 1,2,4-TRIAZINE-4-AMINE DERIVATIVES Public/Granted day:2023-01-19
Information query
IPC分类: